Generally, cancer patients with lower LINC00520 expression levels have a higher overall survival rate (OS), including lung cancer (11), LUAD (13), NSCLC (10), PTC (14), CRC (15), MM (16, 18), and NPC (21). This evidence concerns the gene LINC00520 and lung carcinoma.